日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Business

Medicine trade tops $100b in 2015

By Wang Wen | China Daily | Updated: 2016-02-08 16:03

China's trade in medicines hit an all-time high of $102 billion last year.

The latest figures from the China Chamber of Commerce for Import and Export of Medicines and Health Products show the value was a 4.73 percent increase on 2014, and this year total export-import volumes are expected to rise again, by 3 to 5 percent.

Xu Ming, the chamber's deputy director, called the overall growth "healthy and stable", adding, however, that the Chinese export market had slowed.

Medicine imports were worth $46.2 billion, up 7.3 percent, while exports grew a slower 2.7 percent to $56.4 billion.

"That import growth indicates the Chinese domestic market has huge potential, as it is now the second-largest globally after the United States," said Xu.

The weaker export figures were largely indicative of an ongoing global economic slowdown, Xu said, and coupled with a weaker yuan, they put China on the back foot as an international medicine supplier.

Exports to the US performed well, even though some other main markets dropped. Volumes to the US grew 7.72 percent compared with the previous year and it is now China's second-largest medicine export market after Europe, where demand dropped 0.22 percent.

Xu remains positive that Chinese companies are making strong headway in their moves to expand trade abroad.

Some have been expanding through investment and merger, which is often a more complicated route than simply selling their products directly.

"It's astonishing how some Chinese companies have performed so well in overseas investments," Xu said.

One of the sector's most significant developments in 2015 was by a consortium led by Shanghai Fosun Pharmaceutical Group Co Ltd, which bought Ambrx Inc, a US biotechnology company focusing on molecular medicine.

The acquisition group also involved HOPU Jinghua (Beijing) Investment Consultancy Co Ltd, China Everbright Ltd's healthcare fund, and Wuxi PharmaTech, and the purchase included some valuable global biotechnology.

Fosun Pharma's Chairman Chen Qiyu said the acquisition would "produce a dramatic synergistic effect on Fosun's current development system".

Ambrx is now expected to build a global products development center in China, Chen said.

Other moves saw Chinese companies signing agreements with foreign companies to sell their products overseas.

Jiangsu Heng Rui Medicine Co Ltd, for instance, authorized US-based pharmaceutical company Incyte Corp to develop and sell its PD-1 antibody product outside China in September, with the Delaware firm paying $795 million for the right.

wangwen@chinadaily.com.cn

 

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 狠狠干五月天 | 亚洲aa视频 | 国产午夜麻豆影院在线观看 | 色八区 | 国产精品高潮视频 | 免费成人av片 | 国产视频手机在线 | 亚洲高清视频在线播放 | 五月天青青草 | h色网站在线观看 | 久草免费av| 亚洲成人偷拍 | 国产精品免费久久久 | 中文字幕天堂在线 | 亚洲婷婷网| 欧美亚洲一区二区三区 | 日韩欧美成 | 圆产精品久久久久久久久久久 | 国产视频分类 | 精品国产18久久久久久 | h片免费在线观看 | 国产色网站 | 在线观看国产黄色 | 天天干天天噜 | 国产jizz18女人高潮 | 五月婷婷一区二区 | 999精品| 黄色网址av | 日韩香蕉网 | 91视频在线观看网站 | 蜜桃av一区二区三区 | 免费在线观看av网站 | 成人午夜免费视频 | 男人的天堂欧美 | 亚洲国产精品视频 | 爱爱久久 | 日本欧美在线 | 自拍偷在线精品自拍偷无码专区 | 日韩三级一区二区三区 | 国产探花视频在线观看 | 综合久久综合 |